Open Innovation in the Pharmaceutical Small Firm Sector

Mit dem PharmaInnovationsLotsen offene Innovationsprozesse gestalten

JournalIndustrie Management
Issue Volume 27, 2011, Edition 5, Pages 9-12
Share Cite Download

Abstract

Innovation is a central determinant of the competitiveness of a company. The discovery, development and realization of innovative ideas are, however, bound up with challenges and risks. Against this backdrop, new paths and resources must be demonstrated, particularly for small and mid-sized enterprises (SME). This article is concerned with the open-innovation approach in the pharmaceutical industry and describes the interaction between research and practice to open the existing innovation processes in three SME.

Keywords

Access limited

You are currently not logged in / not yet registered.

In order to download the desired file(s), you must be logged in and have an appropriate inclusive subscription. Alternatively, you can also obtain access by paying a one-off fee.

Subscription included Purchase
without 29,00 €
Digital 0,00 €
Expert 0,00 €
Professional 0,00 €

Download for one time 29,00 €

All prices include 7% VAT

After purchasing access rights, you will automatically be redirected back to this page.


Potentials: Innovation